Notably, circulating biomarker analyses in melanoma patients demonstrated that elevated fractalkine contributed to a gene signature predictive of irAEs36 and that increases in IL-2RA coincided with the development of symptomatic pneumonitis73. The gene discussed is CX3CL1; the disease is melanoma.